{"id":849,"date":"2021-12-15T18:49:41","date_gmt":"2021-12-15T18:49:41","guid":{"rendered":"https:\/\/chartwellpartners.com\/?p=849"},"modified":"2021-12-15T18:49:41","modified_gmt":"2021-12-15T18:49:41","slug":"hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer","status":"publish","type":"post","link":"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/","title":{"rendered":"HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer"},"content":{"rendered":"<p>Chartwell Partners was honored to work with HemoShear Therapeutics on the recruitment of Pat Horn as Chief Medical Officer. Based in Charlotteville, VA, HemoShear is a privately held clinical stage company developing treatments for rare metabolic disorders with significant unmet patient need. HST5040, an oral small molecule drug, is HemoShear\u2019s lead development program and is now in early phase 2 studies for methylmalonic acidemia and propionic acidemia.<\/p>\n<p>&nbsp;<\/p>\n<p>Pat joins from Albireo Pharma where he served as Chief Medical Officer since July 2018. While at the company, he led the team that achieved accelerated marketing approvals in the US and Europe for Bylvay<sup>TM<\/sup>\u00a0in progressive familial intrahepatic cholestasis (PFIC).\u00a0 He also designed and initiated pivotal clinical development programs in biliary atresia and Alagille syndrome.\u00a0 Prior to Albireo, he led clinical development programs in hereditary angioedema, homocystinuria, and infectious disease. Dr. Horn has formal training and extensive experience in clinical pharmacology. \u00a0He received his MD and PhD from the University of Chicago and completed a pediatric residency at Boston Children\u2019s Hospital. Prior to transitioning to industry, Dr. Horn was a practicing pediatrician at major academic institutions in Chicago.<\/p>\n<p>&nbsp;<\/p>\n<p>For more information, please see HemoShear\u2019s press release &#8211; <a href=\"https:\/\/hemoshear.com\/news\/hemoshear-therapeutics-appoints-patrick-horn-md-phd-chief-medical-officer\">https:\/\/hemoshear.com\/news\/hemoshear-therapeutics-appoints-patrick-horn-md-phd-chief-medical-officer<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chartwell Partners was honored to work with HemoShear Therapeutics on the recruitment of Pat Horn as Chief Medical Officer. Based in Charlotteville, VA, HemoShear is a privately held clinical stage company developing treatments for rare metabolic disorders with significant unmet patient need. HST5040, an oral small molecule drug, is HemoShear\u2019s lead development program and is&#8230;<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_links_to":"","_links_to_target":""},"categories":[10],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer - Chartwell Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer - Chartwell Partners\" \/>\n<meta property=\"og:description\" content=\"Chartwell Partners was honored to work with HemoShear Therapeutics on the recruitment of Pat Horn as Chief Medical Officer. Based in Charlotteville, VA, HemoShear is a privately held clinical stage company developing treatments for rare metabolic disorders with significant unmet patient need. HST5040, an oral small molecule drug, is HemoShear\u2019s lead development program and is...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Chartwell Partners\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-15T18:49:41+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@chartwellus\" \/>\n<meta name=\"twitter:site\" content=\"@chartwellus\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/chartwellpartners.com\/#organization\",\"name\":\"Chartwell Partners\",\"url\":\"https:\/\/chartwellpartners.com\/\",\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/chartwell-partners\/\",\"https:\/\/twitter.com\/chartwellus\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/chartwellpartners.com\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/05\/logo.svg\",\"contentUrl\":\"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/05\/logo.svg\",\"caption\":\"Chartwell Partners\"},\"image\":{\"@id\":\"https:\/\/chartwellpartners.com\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/chartwellpartners.com\/#website\",\"url\":\"https:\/\/chartwellpartners.com\/\",\"name\":\"Chartwell Partners\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/chartwellpartners.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/chartwellpartners.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#webpage\",\"url\":\"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/\",\"name\":\"HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer - Chartwell Partners\",\"isPartOf\":{\"@id\":\"https:\/\/chartwellpartners.com\/#website\"},\"datePublished\":\"2021-12-15T18:49:41+00:00\",\"dateModified\":\"2021-12-15T18:49:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/chartwellpartners.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#webpage\"},\"author\":{\"@id\":\"https:\/\/chartwellpartners.com\/#\/schema\/person\/8ec60ae4e9acc2e16b16922de3e7d77d\"},\"headline\":\"HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer\",\"datePublished\":\"2021-12-15T18:49:41+00:00\",\"dateModified\":\"2021-12-15T18:49:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#webpage\"},\"wordCount\":214,\"publisher\":{\"@id\":\"https:\/\/chartwellpartners.com\/#organization\"},\"articleSection\":[\"HEALTHCARE\"],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/chartwellpartners.com\/#\/schema\/person\/8ec60ae4e9acc2e16b16922de3e7d77d\",\"name\":\"jblunk\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/chartwellpartners.com\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c1a825b298f1a058d60125284ac52cec?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c1a825b298f1a058d60125284ac52cec?s=96&d=mm&r=g\",\"caption\":\"jblunk\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer - Chartwell Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/","og_locale":"en_US","og_type":"article","og_title":"HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer - Chartwell Partners","og_description":"Chartwell Partners was honored to work with HemoShear Therapeutics on the recruitment of Pat Horn as Chief Medical Officer. Based in Charlotteville, VA, HemoShear is a privately held clinical stage company developing treatments for rare metabolic disorders with significant unmet patient need. HST5040, an oral small molecule drug, is HemoShear\u2019s lead development program and is...","og_url":"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/","og_site_name":"Chartwell Partners","article_published_time":"2021-12-15T18:49:41+00:00","twitter_card":"summary_large_image","twitter_creator":"@chartwellus","twitter_site":"@chartwellus","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/chartwellpartners.com\/#organization","name":"Chartwell Partners","url":"https:\/\/chartwellpartners.com\/","sameAs":["https:\/\/www.linkedin.com\/company\/chartwell-partners\/","https:\/\/twitter.com\/chartwellus"],"logo":{"@type":"ImageObject","@id":"https:\/\/chartwellpartners.com\/#logo","inLanguage":"en-US","url":"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/05\/logo.svg","contentUrl":"https:\/\/chartwellpartners.com\/wp-content\/uploads\/2021\/05\/logo.svg","caption":"Chartwell Partners"},"image":{"@id":"https:\/\/chartwellpartners.com\/#logo"}},{"@type":"WebSite","@id":"https:\/\/chartwellpartners.com\/#website","url":"https:\/\/chartwellpartners.com\/","name":"Chartwell Partners","description":"","publisher":{"@id":"https:\/\/chartwellpartners.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chartwellpartners.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#webpage","url":"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/","name":"HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer - Chartwell Partners","isPartOf":{"@id":"https:\/\/chartwellpartners.com\/#website"},"datePublished":"2021-12-15T18:49:41+00:00","dateModified":"2021-12-15T18:49:41+00:00","breadcrumb":{"@id":"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/chartwellpartners.com\/"},{"@type":"ListItem","position":2,"name":"HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer"}]},{"@type":"Article","@id":"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#article","isPartOf":{"@id":"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#webpage"},"author":{"@id":"https:\/\/chartwellpartners.com\/#\/schema\/person\/8ec60ae4e9acc2e16b16922de3e7d77d"},"headline":"HemoShear Therapeutics names Patrick Horn, MD, PhD, as Chief Medical Officer","datePublished":"2021-12-15T18:49:41+00:00","dateModified":"2021-12-15T18:49:41+00:00","mainEntityOfPage":{"@id":"https:\/\/chartwellpartners.com\/healthcare\/hemoshear-therapeutics-names-patrick-horn-md-phd-as-chief-medical-officer\/#webpage"},"wordCount":214,"publisher":{"@id":"https:\/\/chartwellpartners.com\/#organization"},"articleSection":["HEALTHCARE"],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/chartwellpartners.com\/#\/schema\/person\/8ec60ae4e9acc2e16b16922de3e7d77d","name":"jblunk","image":{"@type":"ImageObject","@id":"https:\/\/chartwellpartners.com\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/c1a825b298f1a058d60125284ac52cec?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1a825b298f1a058d60125284ac52cec?s=96&d=mm&r=g","caption":"jblunk"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/posts\/849"}],"collection":[{"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/comments?post=849"}],"version-history":[{"count":0,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/posts\/849\/revisions"}],"wp:attachment":[{"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/media?parent=849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/categories?post=849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chartwellpartners.com\/wp-json\/wp\/v2\/tags?post=849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}